BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Balaha M, Kandeel S, Barakat W. Carvedilol suppresses circulating and hepatic IL-6 responsible for hepatocarcinogenesis of chronically damaged liver in rats. Toxicology and Applied Pharmacology 2016;311:1-11. [DOI: 10.1016/j.taap.2016.10.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Lelou E, Corlu A, Nesseler N, Rauch C, Mallédant Y, Seguin P, Aninat C. The Role of Catecholamines in Pathophysiological Liver Processes. Cells 2022;11:1021. [DOI: 10.3390/cells11061021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bayraktutan Z. 4 hidroksi fenilboronik asidin lipopolisakkarit ile indüklenmiş karaciğer hasarı üzerine muhtemel koruyucu etkilerinin incelenmesi. Journal of Boron 2022. [DOI: 10.30728/boron.1057322] [Reference Citation Analysis]
3 Bryniarski P, Nazimek K, Marcinkiewicz J. Immunomodulatory properties of antihypertensive drugs and digitalis glycosides. Expert Rev Cardiovasc Ther 2022. [PMID: 35130796 DOI: 10.1080/14779072.2022.2039627] [Reference Citation Analysis]
4 Li C, Salmen SH, Awad Alahmadi T, Priya Veeraraghavan V, Krishna Mohan S, Natarajan N, Subramanian S. Anticancer effect of Selenium/Chitosan/Polyethylene glycol/Allyl isothiocyanate nanocomposites against diethylnitrosamine-induced liver cancer in rats. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.02.012] [Reference Citation Analysis]
5 Fallah M, Davoodvandi A, Nikmanzar S, Aghili S, Mirazimi SMA, Aschner M, Rashidian A, Hamblin MR, Chamanara M, Naghsh N, Mirzaei H. Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer. Biomed Pharmacother 2021;142:112024. [PMID: 34399200 DOI: 10.1016/j.biopha.2021.112024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
6 Wijarnpreecha K, Li F, Xiang Y, Xu X, Zhu C, Maroufy V, Wang Q, Tao W, Dang Y, Pham HA, Zhou Y, Li J, Zhang X, Xu H, Taner CB, Yang L, Tao C. Nonselective beta-blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States. Aliment Pharmacol Ther 2021;54:481-92. [PMID: 34224163 DOI: 10.1111/apt.16490] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
7 de S. L. Oliveira ALC, dos Santos-silva AM, da Silva-júnior AA, Garcia VB, de Araújo AA, de Geus-oei L, Chan AB, Cruz LJ, de Araújo Júnior RF. Cholesterol-functionalized carvedilol-loaded PLGA nanoparticles: anti-inflammatory, antioxidant, and antitumor effects. J Nanopart Res 2020;22. [DOI: 10.1007/s11051-020-04832-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ma Z, Liu X, Zhang Q, Yu Z, Gao D. Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS‑mediated PI3K/AKT signaling pathway. Oncol Rep 2019;41:811-8. [PMID: 30483797 DOI: 10.3892/or.2018.6873] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
9 García ER, Gutierrez EA, de Melo FCSA, Novaes RD, Gonçalves RV. Flavonoids Effects on Hepatocellular Carcinoma in Murine Models: A Systematic Review. Evid Based Complement Alternat Med 2018;2018:6328970. [PMID: 29681978 DOI: 10.1155/2018/6328970] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]